Form 4: IGC Pharma Executive Reports Stock Transaction
Insider Transaction (Form 4)
Claudia Grimaldi, PFO and a Director of IGC Pharma, Inc., reported a transaction in 150,000 shares of common stock on September 25, 2026.
Summary
- Bona fide gift: disposed of 150,000 Common Stock on September 25, 2026; holds 3,271,092 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Claudia Grimaldi — Director, Officer (PFO)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-25 | Bona fide gift | Common Stock | 150,000 | — | — | 3,271,092 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-25 | Bona fide gift (150,000 shares) |
Keywords
insider transaction, Form 4, IGC, IGC Pharma, Inc., neutral, Claudia Grimaldi
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.